Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Forest Pharmaceuticals Inc.
Current Parent CompanyAbbVie
Parent at the Time of the Penalty Announcement subscribe to see this data field
Recap of Ownership Changes subscribe to see this data field
Penalty: $60,000,000
Year: 2010
Date: September 15, 2010
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: off-label or unapproved promotion of medical products
Violation Description: Forest Pharmaceuticals agreed to pay $60 million to settle multistate litigation alleging that it caused false claims to be submitted to government health care programs for the drugs Levothroid, Celexa, and Lexapro. This was part of a larger $149 million settlement involving the federal government; see the Violation Tracker entry at (click here). The company also paid $164 million in a related criminal case; see (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: Illinois
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.